Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats

Experimental Gerontology

Volumn 46, Issue 4, 2011, Pages 309-315

  Leite, Marlon Régis ^a   Wilhelm, Ethel A ^a   Jesse, Cristiano R ^a   Brandão, Ricardo ^a   Nogueira, Cristina Wayne ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Aging; Caffeine; Memory; Novel object recognition memory; Oxidative stress; SCH58261

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; CAFFEINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; MALE; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ADENOSINE A2 RECEPTOR ANTAGONISTS; AGING; ANIMALS; ASCORBIC ACID; BRAIN; CAFFEINE; MALE; MEMORY; MEMORY DISORDERS; OXIDATIVE STRESS; PYRIMIDINES; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRIAZOLES;

RATTUS;

EID: 79952695020     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.11.034     Document Type: Article

References (82)

1. Agostinho P., Caseiro P., Rego A.C., Duarte E.P., Cunha R.A., Oliveira C.R. Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress. Neurochem. Int. 2000, 36:255-265.
2. 2 receptors in the striatum of young adult and aged rats. Neurochem. Int. 2004, 45:733-738.
3. Alhaider I.A., Aleisa A.M., Tran T.T., Alzoubi K.H., Alkadhi K.A. Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity. Sleep 2010, 33:437-444.
4. Almeida C.G., de Mendonça A., Cunha R.A., Ribeiro J.A. Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices. Neurosci. Lett. 2003, 339:127-130.
5. Angelucci M.E., Vital M.A., Cesario C., Zadusky C.R., Rosalen P.L., da Cunha C. The effect of caffeine in animal models of learning and memory. Eur. J. Pharmacol. 1999, 373:135-140.
6. Arendash G.W., Schleif W., Rezai-Zadeh K., Jackson E.K., Zacharia L.C., Cracchiolo J.R., Shippy D., Tan J. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 2006, 142:941-952.
7. Arendash G.W., Mori T., Cao C., Mamcarz M., Runfeldt M., Dickson A., Rezai-Zadeh K., Tane J., Citron B.A., Lin X., Echeverria V., Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer's disease mice. J. Alzheimers Dis. 2009, 17:661-680.
8. + ATPase inhibition induced by arginine administration is prevented by Vitamins E and C. Neurochem. Res. 2003, 28:825-829.
9. 2A receptor antagonists. Br. J. Pharmacol. 2002, 135:1435-1442.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
11. Brunelli M., Garcia-Gil M., Mozzachiodi R., Scuri R., Zaccardi M.L. Neurobiological principles of learning and memory. Arch. Ital. Biol. 1997, 135:15-36.
12. 2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by β-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. 2009, 29:14741-14751.
13. Canas P.M., Duarte J.M.N., Rodrigues R.J., Köfalvi A., Cunha R.A. Modification upon aging of the density of presynaptic modulation systems in the hippocampus. Neurobiol. Aging 2009, 30:1877-1884.
14. Carfagna M.A., Ponsler G.D., Muhoberac B.B. Inhibition of ATPase activity in rat synaptic plasma membranes by simultaneous exposure to metals. Chem. Biol. Interact. 1996, 100:53-65.
15. Charlton K.E., Rabinowitz T.L., Geffen L.N., Dhansay M.A. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J. Nutr. Health Aging 2004, 8:99-107.
16. 2A adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci. 2001, 143:1-6.
17. 2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J. Neurochem. 2010, 112:453-462.
18. Corodimas K.P., Pruitt J.C., Stieg J.M. Acute exposure to caffeine selectively disrupts context conditioning in rats. Psychopharmacology (Berl) 2000, 152:376-382.
19. 2A receptor stimulation on GABA release from the striatum of young and aged rats in vivo. NeuroReport 1999, 10:3933-3937.
20. 2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuropharmacology 2000, 11:2591-2595.
21. Costa M.S., Botton P.H., Mioranzza S., Souza D.O., Porciúncula L.O. Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tyrosine kinase receptor (TrkB) content in mice. Neuroscience 2008, 153:1071-1078.
22. Costenla A.R., Cunha R.A., Mendonça A. Caffeine, adenosine receptors, and synaptic plasticity. J. Alzheimers Dis. 2010, 20:25-34.
23. 2A receptor blockade. Purinergic Signal. 2005, 1:111-134.
24. Cunha R.A. Cafeína, receptores de adenosina, memoria y enfermedad de Alzheimer. Med. Clín. 2008, 131:790-795.
25. Cunha R.A., Agostinho P.M. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J. Alzheimers Dis. 2010, 20:95-116.
26. 2A adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. NeuroReport 1995, 6:1583-1588.
27. Cunha G.M.A., Canas P.M., Melo C.S., Hockemeyer J., Müller C.E., Oliveira C.R., Cunha R.A. Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801. Exp. Neurol. 2008, 210:776-781.
28. 2A receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp. Neurol. 2007, 203:241-245.
29. De Lima M.N., Laranja D.C., Caldana F., Bromberg E., Roesler R., Schröder N. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp. Gerontol. 2005, 40:506-511.
30. de Mendonça A., Ribeiro J.A. Endogenous adenosine modulates long-term potentiation in the hippocampus. Neuroscience 1994, 62:385-390.
31. Dröge W., Schipper H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007, 6:361-370.
32. Duarte J.M., Carvalho R.A., Cunha R.A., Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J. Neurochem. 2009, 111:368-379.
33. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. Behavioural data. Behav. Brain Res. 1988, 31:47-59.
34. Erecinska M., Silver I.A. ATP and brain function. J. Cereb. Blood Flow Metab. 1989, 9:2-19.
35. Erickson C.A., Barnes C.A. The neurobiology of memory changes in normal aging. Exp. Gerontol. 2003, 38:61-69.
36. Fiske C.H., Subbarow Y.J. The calorimetric determination of phosphorus. Biol. Chem. 1925, 66:375-381.
37. Fredholm B.B., Battig K., Holmen J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharm. Rev. 1999, 51:83-133.
38. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 2001, 53:527-552.
39. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 2005, 63:191-270.
40. Gevaerd M.S., Takahashi R.N., Silveira R., Da Cunha C. Caffeine reverses the memory disruption induced by intra-nigral MPTP injection in rats. Brain Res. Bull. 2001, 55:101-106.
41. Gibbs M.E., Ng K.T. Psychobiology of memory: towards a model of memory formation. Behav. Rev. 1977, 1:113-136.
42. + ATPase activity in neurons and glial cells of the olfactory cortex of the rat brain during the development of long-term potentiation. Neurosci. Behav. Physiol. 1997, 27:49-52.
43. Gómez-Ruiz J.A., Leake D.S., Ames J.M. In vitro antioxidant activity of coffee compounds and their metabolites. J. Agric. Food Chem. 2007, 55:6962-6969.
44. Halliwell B. Free radicals, protein and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 1996, 24:1023-1027.
45. Heldt S.A., Stanek L., Chhatwal J.P., Ressler K.J. Hippocampus-specific deletion of bdnf in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 2007, 12:656-670.
46. 2 nanoparticles. Biomaterials 2010, 31:8043-8050.
47. 2A receptor knockout mice. Pain 2007, 129:287-294.
48. Jacques-Silva M.C., Nogueira C.W., Broch L.C., Flores E.M., Rocha J.B.T. Diphenyl diselenide and ascorbic changes deposition of selenium and ascorbic in liver and brain of mice. Pharmacol. Toxicol. 2001, 88:119-125.
49. Jayakumar T., Thomas P.A., Geraldine P. Protective effect of an extract of the oyster mushroom, Pleurotus ostreatus, on antioxidants of major organs of aged rats. Exp. Gerontol. 2007, 42:183-191.
50. + ATPase, glutathione-s-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci. Lett. 2001, 301:1-4.
51. Landmark K. Could intake of vitamins C and E inhibit development of Alzheimer dementia?. Tidsskr. Nor. Laegeforen. 2006, 126:159-161.
52. Liu R., Liu I.Y., Bi X., Thompson R.F., Doctrow S.R., Malfroy B., et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl Acad. Sci. USA 2003, 100:8526-8531.
53. 2A receptors in the limbic cortex, but not striatum, of aged rats. J. Neurochem. 1999, 73:1733-1738.
54. Lu J., Zheng Y.L., Luo L., Wu D.M., Sun D.X., Feng Y.J. Quercetin reverses d-galactose induced neurotoxicity in mouse brain. Behav. Brain Res. 2006, 171:251-260.
55. 1. Neurosci. Lett. 1999, 274:91-94.
56. Mendonça A., Cunha R.A. Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks. J. Alzheimers Dis. 2010, 20:249-252.
57. 1 region of the rat hippocampus. Neuropharmacology 1997, 36:161-167.
58. Nehling A., Armspach J.P., Namer I.J. SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence. Dialogues Clin. Neurosci. 2010, 12:255-263.
59. Ng K.T., Gibbs M.E. Stages in memory formation: a review. Neural and Behavioural Plasticity: The Use of the Domestic Chick as a Model 1991, 351-369. Oxford University Press, Oxford, UK. R.J. Andrew (Ed.).
60. Norman G., Eacott M.J. Impaired object recognition with increasing levels of feature ambiguity in rats with perirhinal cortex lesions. Behav. Brain Res. 2004, 148:79-91.
61. Paleologos M., Cumming R.G., Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am. J. Epidemiol. 1998, 148:45-50.
62. Pardon M.C., Perez-Diaz F., Joubert C., Cohen-Salmon C. Age dependent effects of a chronic ultramild stress procedure on an open field behavior in B6D2F1 female mice. Physiol. Behav. 2000, 70:7-13.
63. Pires V.A., Pamplona F.A., Pandolfo P., Fernandes D., Prediger R.D.S., Takahashi R.N. Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder. Behav. Pharmacol. 2009, 20:134-145.
64. Pires V.A., Pamplona F.A., Pandolfo P., Prediger R.D., Takahashi R.N. Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD). Behav. Brain Res. 2010, 215:39-44.
65. 2A receptors. Neurobiol. Aging 2005, 26:957-964.
66. Quevedo J., Vianna M.R., Martins M.R., Barichello T., Medina J.H., Roesler R., Izquierdo I. Protein synthesis, PKA, and MAP kinase are differentially involved in short- and long-term memory in rats. Behav. Brain Res. 2004, 154:339-343.
67. 2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J. Neurophysiol. 2003, 90:1295-1303.
68. 2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 2008, 57:121-134.
69. Rego A.C., Areias F.M., Santos M.S., Oliveira C.R. Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury. Neurochem. Res. 1999, 24:351-358.
70. Ribeiro J.A., Sebastião A.M. Caffeine and adenosine. J. Alzheimers Dis. 2010, 20:3-15.
71. Riedel W.J., Jolles J. Cognition enhancers in age-related cognitive decline. Drugs Aging 1996, 8:245-274.
72. Rodrigues R.J., Canas P.M., Lopes L.V., Oliveira C.R., Cunha R.A. Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol. Aging 2008, 29:1597-1601.
73. + ATPase activity inhibition-induced amnesia on the step-through passive avoidance task in gonadectomized mice. Pharmacol. Res. 2004, 49:151-159.
74. Schröder N., O'Dell S.J., Marshall J.F. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 2003, 49:89-96.
75. Shahidi S., Komaki A., Mahmoodi M., Atrvash N., Ghodrati M. Ascorbic acid supplementation could affect passive avoidance learning and memory in rat. Brain Res. Bull. 2008, 76:109-113.
76. 2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. Neurobiol. Dis. 2007, 27:182-189.
77. Siqueira I.R., Fochesatto C., De Andrade A., Santos M., Hagen M., Bello-Klein A., Netto C.A. Total antioxidant capacity is impaired in different structures from aged brain. Int. J. Dev. Neurosci. 2005, 23:663-671.
78. Takahashi R.N., Pamplona F.A., Prediger R.D. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front. Biosci. 2008, 13:2614-2632.
79. Viani P., Ceravto G., Fiorilli A., Cestaro B. Age-related differences in synaptosomal peroxidative damage and membrane properties. J. Neurochem. 1991, 56:253-258.
80. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol. Bull. 1976, 83:482-504.
81. + ATPase activity in rat hippocampus. Physiol. Behav. 2004, 80:475-479.
82. Zhan H., Tada T., Nakazato F., Tanaka Y., Hongo K. Spatial learning transiently disturbed by intraventricular administration of ouabain. Neurol. Res. 2004, 26:35-40.